Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Interactive Brokers reported Q3 results yesterday and the immediate market reaction was negative, with the stock falling 3.8% on the day to $84.14 and now down 4.1% on the week.
The stock's reaction fits a pattern. The previous earnings print, in July, produced a modest 2% gain that reversed within five days, finishing the week down 0.8%. Before yesterday's session, the stock had already given back 7.9% over the past month, so the market had trimmed some optimism ahead of the release. The price is now back around levels that have acted as a floor in recent months. Peers fell too, though IBKR underperformed on the day: MS dropped 2.7%, fell 1.5%, and was the hardest hit at 8.5%, suggesting broader sector pressure rather than company-specific alarm.
The analyst community has not moved to cut targets in response. The consensus remains buy, with a mean price target of $104.04 against a close of $84.14, implying roughly 24% upside. Evercore ISI initiated coverage at Outperform with a $100 target as recently as October 12, one day before the print. Barclays held Overweight at $115 and Bank of America maintained Buy at $116, both set within the past two weeks. The one dissenting voice is UBS, which trimmed its target slightly to $101 while holding Neutral. The direction of analyst travel before the print was firmly constructive, and none of the bullish targets have been publicly walked back since results landed.
Short interest had already climbed sharply ahead of the release. It rose 11% in one week to 3% of the free float, up 66% from a month ago. That build now looks like positioning ahead of a known event risk rather than a structural bear thesis. The borrow market still does not support an aggressive short reading: availability remains essentially unlimited, with over 264 million shares available against a short position of around 13.6 million, and cost to borrow is under 0.4%. The ORTEX short score of 34.6 sits in the middle of its recent range, well below levels that would signal any squeeze risk. Options positioning had tilted slightly more defensive before the print, with the put/call ratio at 0.78, roughly 1.4 standard deviations above its 20-day mean, but that hedging demand was modest rather than extreme, and the ratio remains well below its 52-week high of 0.93.
The print has now been delivered. What remains to test is whether the analyst targets in the $100 to $116 range are revised downward in the days ahead, or whether the sell-off is treated as an entry point by a Street that, heading in, was more bullish on IBKR than on almost any comparable name.
See the live data behind this article on ORTEX.
Open IBKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
